Evaluation of a point-of-care assay for detecting SARS-CoV-2

In this application note, the performance of the LumiraDx SARS-CoV-2 & Flu A/B Test was evaluated versus RT-PCR

Related Keywords

,Application Note ,Lumiradx Platform ,Covid 19 ,Point Of Care ,Flu ,Immunofluorescence ,